Clinical Trials Directory

Trials / Completed

CompletedNCT04698889

Effect of Ingestion of Human, Cow, and Modified-cow Milk, on Glucose and Hormone Responses in Humans.

Study of the Effects of Ingestion of Natural Human, Natural Cow, and Modified-cow Milk, on Glucose, Amino Acids, Insulin, and Incretin Responses in Humans

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17 (actual)
Sponsor
University of Padova · Academic / Other
Sex
All
Age
20 Years – 35 Years
Healthy volunteers
Accepted

Summary

Human milk, despite a much lower protein content, is as effective as cow milk on insulin stimulation under iso-lactose conditions. The causes for such a similar potency are unknown. This effect could be due to incretin and amino-acid responses, and/or to milk-protein interactions.In this study the investigators will address the above question(s) by testing, in young healthy volunteers, the effects of natural cow and human milk, as well as of the manipulation of the casein and whey protein content in cow milk, on insulin, C-peptide, GLP-1 and GIP secretion, as well as on circulating amino acids.

Detailed description

Objective: To determine plasma glucose, insulin, C-peptide, glucagon-like polypeptide-1 (GLP-1), glucose-inhibitory-polypeptide (GIP) and amino-acid responses, following administration of human and cow milk, either natural or with experimentally-modified casein and whey-protein content(s). Design. Young healthy volunteers of both sexes will receive iso-lactose loads (0.36 g lactose / kg body weight) of: natural cow milk; natural human milk; and of cow milk with modified casein and whey protein contents. Blood samples will be frequently collected over 4 hours. Plasma glucose, amino acids, insulin and incretin concentrations will be measured.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTnatural cow
DIETARY_SUPPLEMENThigh protein cow milk
DIETARY_SUPPLEMENTnatural human
DIETARY_SUPPLEMENTlow protein cow milk

Timeline

Start date
2015-04-07
Primary completion
2019-02-05
Completion
2020-10-01
First posted
2021-01-07
Last updated
2021-01-07

Source: ClinicalTrials.gov record NCT04698889. Inclusion in this directory is not an endorsement.